Abstract
Gene therapy holds promise for treating previously untreatable retinal disorders. The most promising approaches use gene transfer vectors derived from adeno-associated virus (AAV) to supplement a gene function in the affected cell type. One example is gene therapy for achromatopsia which affects daylight vision. In this case, recombinant AAV (rAAV) vectors are being developed to specifically target cone photoreceptors. Development of rAAV vectors could be facilitated by the use of in vitro models. In this chapter we provide a protocol which utilizes mouse 661W cells, an in vitro model of cone photoreceptors for evaluation of the transduction efficacy of rAAV vectors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mühlfriedel R, Tanimoto N, Schön C, Sothilingam V, Garcia Garrido M, Beck SC, Huber G, Biel M, Seeliger MW, Michalakis S (2017) AAV-mediated gene supplementation therapy in achromatopsia type 2: preclinical data on therapeutic time window and long-term effects. Front Neurosci 11:292. https://doi.org/10.3389/fnins.2017.00292
Michalakis S, Mühlfriedel R, Tanimoto N, Krishnamoorthy V, Koch S, Fischer MD, Becirovic E, Bai L, Huber G, Beck SC, Fahl E, Büning H, Paquet-Durand F, Zong X, Gollisch T, Biel M, Seeliger MW (2010) Restoration of cone vision in the CNGA3−/− mouse model of congenital complete lack of cone photoreceptor function. Mol Ther 18(12):2057–2063. https://doi.org/10.1038/mt.2010.149
Michalakis S, Schön C, Becirovic E, Biel M (2017) Gene therapy for achromatopsia. J Gene Med 19(3). https://doi.org/10.1002/jgm.2944
Schön C, Biel M, Michalakis S (2015) Retinal gene delivery by adeno-associated virus (AAV) vectors: strategies and applications. Eur J Pharm Biopharm 95(Pt B):343–352. https://doi.org/10.1016/j.ejpb.2015.01.009
Crawford MJ, Krishnamoorthy RR, Rudick VL, Collier RJ, Kapin M, Aggarwal BB, Al-Ubaidi MR, Agarwal N (2001) Bcl-2 overexpression protects photooxidative stress-induced apoptosis of photoreceptor cells via NF-kappaB preservation. Biochem Biophys Res Commun 281(5):1304–1312. https://doi.org/10.1006/bbrc.2001.4501
Tan E, Ding XQ, Saadi A, Agarwal N, Naash MI, Al-Ubaidi MR (2004) Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest Ophthalmol Vis Sci 45(3):764–768
Dalkara D, Byrne LC, Klimczak RR, Visel M, Yin L, Merigan WH, Flannery JG, Schaffer DV (2013) In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Sci Transl Med 5(189):189ra176. https://doi.org/10.1126/scitranslmed.3005708
Khabou H, Desrosiers M, Winckler C, Fouquet S, Auregan G, Bemelmans AP, Sahel JA, Dalkara D (2016) Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant -7m8. Biotechnol Bioeng 113(12):2712–2724. https://doi.org/10.1002/bit.26031
Acknowledgments
We thank Dr. Muayyad R. Al-Ubaidi (University of Houston) for the gift of 661W cells.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Wagner, J.E., Schön, C., Becirovic, E., Biel, M., Michalakis, S. (2019). In Vitro Evaluation of AAV Vectors for Retinal Gene Therapy. In: Weber, B.H.F., Langmann, T. (eds) Retinal Degeneration. Methods in Molecular Biology, vol 1834. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-8669-9_24
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8669-9_24
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-8668-2
Online ISBN: 978-1-4939-8669-9
eBook Packages: Springer Protocols